Nephrotoxicity of low-dose methotrexate in guinea pigs: An ultrastructural study

Nephron

Volumn 73, Issue 3, 1996, Pages 462-466

  El Badawi, M G ^a   Abdalla, M A ^a   Bahakin, H M ^a   Fadel, R A ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Guinea pig; Leucovorin; Methotrexate; Nephrotoxicity; Ultrastructure

Indexed keywords

FOLIC ACID ANTAGONIST; FOLIC ACID DERIVATIVE; FOLINIC ACID; METHOTREXATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW SUPPRESSION; CELL SWELLING; CELL ULTRASTRUCTURE; ENDOPLASMIC RETICULUM; GLOMERULUS; GUINEA PIG; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; MITOCHONDRION; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTIDOTES; ANTIMETABOLITES, ANTINEOPLASTIC; BLOOD CELL COUNT; BONE MARROW; GUINEA PIGS; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TUBULES; LEUCOVORIN; METHOTREXATE; MICROSCOPY, ELECTRON;

EID: 0029957061     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189111     Document Type: Article

References (22)

1. Calabresi P. Parks RE: Chemotherapy of neoplastic diseases; in Goodman LS, Gillman A (eds): The Pharmacological Basis of Therapeutics. cd 4. London. Macmillan. 1970.
2. Schornagel JH, McVie JM: The clinical pharmacology of methotrexate. Cancer Treat Rev 1983;10:53-75.
3. Iven H. Brasch H:Tlie effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymcthotrexatc in rabbits. Cancer Chcmolher Pharmacol 1988; 21:337-342.
4. Pitman SW. Frei E: Weekly methotrexate-cal-cium leucovorin rescue: Effect of alkalinization on nephrotoxicity, pharmacokinetics in the C'NS and use in CNS non-Hodgkin's lymphoma. CancerTreat Rep 1977:61:695-701.
5. Maichc AG. Lappalaincn K. Teerenhovi L: Renal insufficiency in patients treated with high dose methotrexate. Acta Oncol 1988:27:73-74.
6. Price P. Thompson H. Besscll EM. Bloom HJ: Renal impairment following the combined use of high-dose methotrexate and procarbazine. Cancer Chcmolher Pharmacol 1988:21:265-267.
7. Condit PT. Chanes RE. Joel W: Renal toxicity of met hot rexate. Cancer 1969:23:126-131.
8. El-Badawi MG, Soliman MA, Haroun EA, Fa-tani JA: Nephrotoxicity of methotrexate in ncphrectomized rats. Al-Azhar Med J 1980:9: 389-392.
9. El-Badawi MG. Amir MH. Dehaba NM. Fa-tani JA, Sabha DM. Mustafa FA: Histological changes following high-dose methotrexate and cisplatinum administration and the influence of dosage scheduling. Chemotherapy 1987:33: 278-282.
10. Zachariae H. Grunnet E, Sogaard H: Accidental kidney biopsies in psoriasis. Br J Dermatol 1976;94:655-657.
11. Miescher PA. F'avre H. Chatelanat F. Mihatsch MJ: Combined stcroid-cyclosporin treatment of chronic autoimmune diseases: Clinical results and assessment of nephrotoxicity by renal biopsy. Klin Wochenschr 1987;65:727-736.
12. Seideman P. Muller-Suur R. Fkman R: Renal effects ofiow-dosc methotrexate in rheumatoid arthritis. J Rheumatol 1993:20:1126-1128.
13. Romolo JL. Goldberg NH. Hande KR. Rosenberg SA: Effect of hydration on plasma-metho-trcxate levels. Cancer Treat Rep 1977;61: 1393-1396.
14. El-Badawi MG. Fatani JA, Bahakim H. Abdal-la MA: Light and electron microscopic obscrva-t ions on the cerebellum of guinea pigs following low-dosc methotrexate. Exp Mol Pathol 1990: 53:211-222.
15. Arrington LR: Introductory Laboratory Animal Science. Danville. Interstate Printers and Publishers. 1978.
16. Schcrmer S: The Blood Morphology of Laboratory Animals, ed 3. Philadelphia. Davis. 1967.
17. Freeman-Narrod M. Kim JS, Ohanissian H. Mills K. Smiley JW. Djerassi I: The effect of high-dose methotrexate on renal tubules as indicated by urinary lysozymc concentration. Cancer 1982;50:2775-2779.
18. Daskal Y, Prestavko AW, Crookc ST: Morphological manifestations of cisplatin analogue in rats: An ultrastructural study; in Prestavko AW, Crooke ST, Carter SK (eds): Cisplatin Current Status and New Developments. New York. Academic Press, 1980, pp 249-269.
19. Carlos GF. Gustavo AM. Santiago P: Cutaneous vasculitis aller intermediate dose of methotrexate (IDMTX). Br J Haematol 1989:72: 591-592.
20. Morrison AB. Panner BJ: Lysosontc induction in experimental potassium deficiency. Am J Pathol 1964:45:295-298.
21. Axline SG. Cohn ZA: in vitro induction of lysosomal enzymes by phagocytosis. J Exp Med 1970.,131:1239-1242.
22. Raso V, Schreiber R: Radioimmunoassay for methotrexate. Cancer Res 1975;35:1407-1410.